Search research articles
Contact Us
Filters
Showing results (111-120 of 183) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2014
Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial
Paulo M Hoff, Daniel F Saragiotto, Carlos H Barrios, et al.
Microorganisms
|
August 26, 2023
Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19
Marilou H Barrios, Suellen Nicholson, Rowena A Bull, et al.
CA: a Cancer Journal for Clinicians
|
February 19, 2020
Enhancing global access to cancer medicines
Javier Cortes, Jose Manuel Perez-García, Antonio Llombart-Cussac, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2022
Effects of capecitabine as part of neo-/adjuvant chemotherapy - A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients
Marion T van Mackelenbergh, Fenja Seither, Volker Möbus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2026
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease
G Curigliano, X Hu, R Dent, et al.
British Journal of Cancer
|
July 1, 2015
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer
P A Jänne, I Smith, G McWalter, et al.
Journal of the National Cancer Institute
|
June 7, 2021
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer
Hope S Rugo, Sherene Loi, Sylvia Adams, et al.
The New England Journal of Medicine
|
October 23, 2018
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Peter Schmid, Sylvia Adams, Hope S Rugo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 20, 2022
International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials
Matthew P Smeltzer, Giorgio V Scagliotti, Heather A Wakelee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer
Suresh S Ramalingam, Fiona Blackhall, Maciej Krzakowski, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 183) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2014
Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial
Paulo M Hoff, Daniel F Saragiotto, Carlos H Barrios, et al.
Microorganisms
|
August 26, 2023
Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19
Marilou H Barrios, Suellen Nicholson, Rowena A Bull, et al.
CA: a Cancer Journal for Clinicians
|
February 19, 2020
Enhancing global access to cancer medicines
Javier Cortes, Jose Manuel Perez-García, Antonio Llombart-Cussac, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 19, 2022
Effects of capecitabine as part of neo-/adjuvant chemotherapy - A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients
Marion T van Mackelenbergh, Fenja Seither, Volker Möbus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2026
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease
G Curigliano, X Hu, R Dent, et al.
British Journal of Cancer
|
July 1, 2015
Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer
P A Jänne, I Smith, G McWalter, et al.
Journal of the National Cancer Institute
|
June 7, 2021
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer
Hope S Rugo, Sherene Loi, Sylvia Adams, et al.
The New England Journal of Medicine
|
October 23, 2018
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Peter Schmid, Sylvia Adams, Hope S Rugo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 20, 2022
International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials
Matthew P Smeltzer, Giorgio V Scagliotti, Heather A Wakelee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancer
Suresh S Ramalingam, Fiona Blackhall, Maciej Krzakowski, et al.
Page
of 19